DK1462107T3 - Fremgangsmåde til kvindelig kontraception og kit til anvendelse i en sådan fremgangsmåde - Google Patents

Fremgangsmåde til kvindelig kontraception og kit til anvendelse i en sådan fremgangsmåde

Info

Publication number
DK1462107T3
DK1462107T3 DK03075905T DK03075905T DK1462107T3 DK 1462107 T3 DK1462107 T3 DK 1462107T3 DK 03075905 T DK03075905 T DK 03075905T DK 03075905 T DK03075905 T DK 03075905T DK 1462107 T3 DK1462107 T3 DK 1462107T3
Authority
DK
Denmark
Prior art keywords
estradiol
beta
estrogen
amount equivalent
progestogen
Prior art date
Application number
DK03075905T
Other languages
English (en)
Inventor
Bennink Herman Jan Tijmen Coelingh
Monique Visser
Original Assignee
Pantarhei Bioscience Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32798964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1462107(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pantarhei Bioscience Bv filed Critical Pantarhei Bioscience Bv
Application granted granted Critical
Publication of DK1462107T3 publication Critical patent/DK1462107T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Packaging Of Special Articles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03075905T 2003-03-28 2003-03-28 Fremgangsmåde til kvindelig kontraception og kit til anvendelse i en sådan fremgangsmåde DK1462107T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03075905A EP1462107B1 (en) 2003-03-28 2003-03-28 Method of female contraception and kit for use in such method

Publications (1)

Publication Number Publication Date
DK1462107T3 true DK1462107T3 (da) 2008-11-03

Family

ID=32798964

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03075905T DK1462107T3 (da) 2003-03-28 2003-03-28 Fremgangsmåde til kvindelig kontraception og kit til anvendelse i en sådan fremgangsmåde

Country Status (7)

Country Link
EP (1) EP1462107B1 (da)
AT (1) ATE409041T1 (da)
DE (1) DE60323725D1 (da)
DK (1) DK1462107T3 (da)
ES (1) ES2314156T3 (da)
PT (1) PT1462107E (da)
SI (1) SI1462107T1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
CN101198335A (zh) * 2004-09-27 2008-06-11 潘塔希生物科学股份有限公司 雌性避孕的方法以及该用途的药盒
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383993A (en) * 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
SE9403389D0 (sv) * 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6265393B1 (en) * 1998-08-07 2001-07-24 Heinrichs William Leroy Prevention of endometriosis signs or symptons
CA2446849A1 (en) * 2001-05-16 2002-11-21 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
US20040198707A1 (en) * 2001-05-23 2004-10-07 Agatha Antonia Magdalena Van Beek Means and method for hormonal contraception
TR200400183T4 (tr) * 2001-05-23 2004-02-23 Pantarhei Bioscience B.V. Hormonal kontrasepsiyon için vasıta ve metot
WO2003041719A1 (en) * 2001-11-15 2003-05-22 Pantarhei Bioscience B.V. Method of contraception in mammalian females and pharmaceutical kit for use in such method

Also Published As

Publication number Publication date
PT1462107E (pt) 2009-01-02
EP1462107B1 (en) 2008-09-24
SI1462107T1 (sl) 2009-02-28
EP1462107A1 (en) 2004-09-29
ATE409041T1 (de) 2008-10-15
DE60323725D1 (de) 2008-11-06
ES2314156T3 (es) 2009-03-16

Similar Documents

Publication Publication Date Title
TR200002207T1 (tr) Slekoksib bileşikleri.
NZ591627A (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
BR0015974A (pt) Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto
EA200600964A1 (ru) Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина
CR7420A (es) Composiciones farmaceuticas que comprenden uno o varios esteroides, uno o varios componentes de tetrahiidrofolatos y vitamina b12
BR0107333A (pt) Formulação farmacêutica, uso da mesma, métodos para tratamento profilático ou terapêutico de um indivìduo sofrendo de, ou susceptìvel a, hipercolesterolemia e diarréia, e, uso de um aglutinante de ácidos biliares
CY1108093T1 (el) Συστημα παραδοσης φαρμακων που αποτελειται απο τετραϋδροξυλιοποιημενο οιστρογονο για χρηση στην ορμονικη αντισυλληψη
CO5190672A1 (es) Composicion para la dosificacion oral, de disolucion instantanea
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
DE60020551D1 (de) Orale formulierung zur verabreichung in den ileum enthaltend einen hemmstoff des ileum-gallensäuretransports
NO982902L (no) FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen
DE69615704T2 (de) Bioadhesive feste arzneimittelform
MXPA04005104A (es) Regimen de dosificacion y composicion farmaceutica para anticoncepcion de emergencia.
AR049197A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
BR0114665A (pt) Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio
HUP0203844A2 (hu) Növekedési hormon kibocsátó tulajdonságú vegyület, ezt tartalmazó gyógyszerkészítmény és alkalmazása
PT1051159E (pt) Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
DK1462107T3 (da) Fremgangsmåde til kvindelig kontraception og kit til anvendelse i en sådan fremgangsmåde
JPS61176524A (ja) 抗炎症組成物
HRP20020258B1 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
TW200731977A (en) Use of estradiol valerate in combination with dienogest for the oral treatment of dysfunctional uterine bleeding in conjunction with oral contraception
RU2225714C2 (ru) Новый набор противозачаточных средств
NO20072687L (no) Farmasoytisk prevensjonspreparat
EA200600156A1 (ru) Пероральная дозировочная форма саквинавирмезилата